Search clinical trials for: Cultivated mucosal epithelial transplantation

Total 38 results

Hospices Civils de Lyon

Recruiting

Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency (FEMJA)

Total Bilateral Limbal Cell Deficiency

France
Mahidol University

Unknown

Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation

Ocular Surface Disease

Thailand
Chang Gung Memorial Hospital

Recruiting

Cultivated Autologous Oral Mucosal Epithelial Transplantation

Limbal Stem Cell Deficiency

Taiwan
Seoul National University Hospital
Ministry of Health & Welfare, Korea

Available

Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

Limbal Stem Cell Deficiency | Ocular Cicatricial Pemphigoid | Stevens-johnson Syndrome | Chemical Burn

Korea, Republic of
Singapore National Eye Centre
Singapore Eye Research Institute

Suspended

Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell Deficiency

Ocular Surface Disease
National Taiwan University Hospital

Terminated

The Application of Oral Mucosal Epithelial Cell Sheets Cultivated on Amino Membrane in Patients Suffering From Corneal Stem Cell Insufficiency or Symblepharon.

Symblepharon | Limbal Insufficiency

Taiwan
He Eye Hospital

Unknown

Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease

Limbal Stem Cell Deficiency
Singapore National Eye Centre
National Medical Research Council (NMRC), Singapore; Singapore Eye Research... and other collaborators

Completed

Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation

Pterygium | Ocular Surface Disease | Chemical Injury | Stevens Johnson Syndrome

Singapore
Massachusetts Eye and Ear Infirmary
Dana-Farber Cancer Institute

Completed

Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft (CALEC)

Limbal Stem Cell Deficiency

United States
Mahidol University

Completed

Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction

Limbal Deficiency | Severe Ocular Surface Damage

Thailand
Siriraj Hospital
Osaka University

Completed

Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency

Limbal Stem-cell Deficiency

Thailand
International Peace Maternity and Child Health...
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Completed

A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Failure (POF)

Infertility | Primary Ovarian Insufficiency | Premature Ovarian Failure

China
The S.N. Fyodorov Eye Microsurgery State Institution

Recruiting

Labial Mucosal Epithelium Grafting for Corneal Limbus Substitution

Limbal Stem-cell Deficiency

Russian Federation
Ethisch Comité UZ Antwerpen
Agentschap voor Innovatie door Wetenschap en Technologie; Fund for Scientific... and other collaborators

Unknown

Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency (LECT)

Limbal Stem Cell Deficiency

Belgium
Centre Hospitalier National d'Ophtalmologie des...
Etablissement Français du Sang

Completed

Cell Therapy in Failure Syndromes in Limbal Stem Cells (TC181)

Limbal Deficiency

France
University of Texas Southwestern Medical Center

Withdrawn

Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces

Corneal Epithelial Dystrophy

United States
Chinese Academy of Sciences
The First Affiliated Hospital of Zhengzhou University

Unknown

Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells

Dry Age-related Macular Degeneration

China
Chinese Academy of Sciences
Beijing Tongren Hospital

Unknown

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Dry Age-related Macular Degeneration

China
CliPS Co., Ltd

Completed

Safety Evaluation of LSCD101 Transplantation for Limbal Stem Cell Deficiency

Limbus Corneae Insufficiency Syndrome | Limbus Corneae

Korea, Republic of
Chinese University of Hong Kong

Active, not recruiting

FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment

Irritable Bowel Syndrome | Fecal Microbiota Transplantation

Hong Kong
CellSeed Inc.

Completed

Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer

Superficial Esophageal Cancer

Japan
Haukeland University Hospital

Completed

Fecal Microbiota Transplantation and ACHIM for Manipulating Gut Microbiota in IBS Patients

Irritable Bowel Syndrome | Dysbiosis

Norway
Instituto de Oftalmología Fundación Conde de Valenciana
National Council of Science and Technology, Mexico

Terminated

ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation

Limbal Stem Cell Deficiency

Mexico
City of Hope Medical Center
National Cancer Institute (NCI)

Suspended

Magrolimab in Combination With Azacitidine After Allogeneic HCTin Treating Patients With High-Risk AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
National Cancer Institute (NCI)

Withdrawn

RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Recruiting

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Congenital Amegakaryocytic Thrombocytopenia | Paroxysmal Nocturnal Hemoglobinuria | Diamond-Blackfan Anemia | Shwachman-Diamond Syndrome | Bone Marrow Failure Syndrome | Hereditary Sideroblastic Anemia | Hematologic Neoplasm With Germline GATA2 Mutation | Hematologic Neoplasm With Germline SAMD9... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Recruiting

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Hematopoietic and Lymphoid Cell Neoplasm | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic Leukemia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Fred Hutchinson Cancer Center

Recruiting

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
National Cancer Institute (NCI)

Recruiting

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy

United States
Fred Hutchinson Cancer Center
National Cord Blood Network

Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Hematopoietic and Lymphoid System Neoplasm | Blastic Plasmacytoid Dendritic Cell Neoplasm | Myeloproliferative Neoplasm | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Chronic...

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Plasma Cell Myeloma | Plasma Cell Leukemia in Remission

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia... and other conditions

United States
Children's Oncology Group

Recruiting

Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Mixed Phenotype Acute Leukemia

United States, Australia, Canada

Search clinical trials for: Cultivated mucosal epithelial transplantation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations